BCO vs IONS
Brinks Company (BCO) versus Ionis Pharmaceuticals Inc (IONS) — a side-by-side from cached financials, not a winner call.
Brinks Company (BCO) is a security & protection services company listed on US.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Latest reported BCO revenue for 2024-12-31 was $5.01B. Net income was $174.7M. Revenue was up 2.8% from 2023-12-31 to 2024-12-31. BCO currently screens at market cap $3.97B and trailing P/E 25.4.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
BCO currently screens at market cap $3.97B and trailing P/E 25.4. IONS currently screens at market cap $12.28B.
Not investment advice. Open the BCO and IONS stock pages for the full models.
Not investment advice.